Correction: Retrospective Study on the Use of Brodalumab for Atopic Dermatitis Management: Real-World Insights - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Retrospective Study on the Use of Brodalumab for Atopic Dermatitis Management: Real-World Insights

  • By

  • Nikolaos Stavropoulos

  • Daniel Myszkowski

  • Dennis Braß

  • Vasileios Dervenis

  • Effimia Poungoura

  • Eggert Stockfleth

  • February 6, 2026

Share

  • 1

    The article discusses the use of brodalumab for managing atopic dermatitis.

  • 2

    A correction was made to replace lebrikizumab with brodalumab in the key summary points.

  • 3

    The study provides real-world insights into the effectiveness of brodalumab.

  • 4

    The correction was officially published in Dermatol Ther (Heidelb).

  • 5

    The DOI for the corrected article is https://doi.org/10.1007/s13555-025-01630-9.

Original Source(s)

Correction: Retrospective Study on the Use of Brodalumab for Atopic Dermatitis Management: Real-World Insights

  • by Nikolaos Stavropoulos, Daniel Myszkowski, Dennis Braß, Vasileios Dervenis, Effimia Poungoura, Eggert Stockfleth

  • February 6, 2026

Related Content

Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)

Comments on Dermatologists’ TikTok Videos on Atopic Dermatitis: Content Analysis

Assessment of Systemic Corticosteroid Use in Individuals with Atopic Dermatitis: Findings from a US Population Study